Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes is a research paper published in Brain (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5P50AG005131-33
UCSD Alzheimer's Disease Research Center P50
National Institutes of Health
Grant: 2R01AG038791-06A
National Institutes of Health
Grant: U01NS090259
National Institutes of Health
Grant: U01NS100610
National Institutes of Health
Grant: U01NS80818
National Institutes of Health
Grant: R25NS098999
National Institutes of Health
Grant: P20GM109025
National Institutes of Health
Grant: U19 AG063911-1
NIA NIH HHS
Grant: R01 AG038791
NINDS NIH HHS
Grant: U01 NS080818
NIA NIH HHS
Grant: U19 AG063911
NIA NIH HHS
Grant: P50 AG005131
Parkinson Study Group
University of California San Diego
Michael J Fox Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals